Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Medical devices comprise electronic equipment, implants, consumables and disposables, surgical instruments and in-vitro ...

A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.

Anomaly detection can be powerful in spotting cyber incidents, but experts say CISOs should balance traditional ...

One concern with bispecific antibody therapies in community settings is managing adverse events, with emerging patterns ...

A one-time injection of Lumevoq demonstrated sustained visual acuity improvements with a favorable safety profile at 5 years ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Lipella's LP-310 Phase 2a trial showed strong efficacy and safety for oral lichen planus. The company plans a Phase 2b trial ...

Legislation that would ban mRNA vaccinations statewide — including the Covid-19 vaccine — drew equal parts support and ...

During a Case-Based Roundtable® event, Neeraj Agarwal, MD, and participants discussed how they might determine which ...

Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...